gemcitabine has been researched along with orabase in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Caffrey, TC; Grunkemeyer, JA; Hollingsworth, MA; Madiyalakan, R; Mehla, K; Nicodemus, CF; O'Connell, KA; Schultes, BC; Singh, PK; Steele, MM; Tremayne, J; Yu, F; Zhu, X | 1 |
Alvarez-Lorenzo, C; de Freitas, LF; de Lima, CSA; Ferreira, AH; Kadłubowski, S; Lugão, AB; Pereira-da-Mota, AF; Rial-Hermida, MI; Varca, GHC; Vivero-Lopez, M | 1 |
2 other study(ies) available for gemcitabine and orabase
Article | Year |
---|---|
Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumors.
Topics: Animals; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; B7-H1 Antigen; Carboxymethylcellulose Sodium; Cytotoxicity, Immunologic; Deoxycytidine; Gemcitabine; Humans; Immunity, Cellular; Mice; Mice, Transgenic; Mucin-1; Pancreatic Neoplasms; Poly I-C; Polylysine; Survival Rate; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |
Mucoadhesive gellan gum-based and carboxymethyl cellulose -based hydrogels containing gemcitabine and papain for bladder cancer treatment.
Topics: Carboxymethylcellulose Sodium; Drug Delivery Systems; Gemcitabine; Humans; Hydrogels; Papain; Polysaccharides, Bacterial; Urinary Bladder; Urinary Bladder Neoplasms | 2023 |